Dubey Shirish, Adebajo A O
Heart of England NHS Trust, Department of Rheumatology, Netherwood, Solihull Hospital, Lode Lane, Solihull B91 2JL, UK.
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.06.2008.0038. Epub 2009 Mar 17.
We present the case of a 57-year-old man who had been on sulphasalazine for 20 years for seropositive non-erosive rheumatoid arthritis and developed a lymphoproliferative disorder, which resolved completely on cessation of sulphasalazine. This is the first report of lymphoproliferative disorder secondary to sulphasalazine. Lymphoproliferative disorders are well recognised with methotrexate and cyclosporine, and recognition of this disorder is critical due to the fact that a number of patients' symptoms will resolve completely with discontinuation of the drug and will not need further treatment. This case report discusses the literature on lymphoproliferative disorders as well as differential diagnoses like drug rash with eosinophilia and systemic symptoms (DRESS) syndrome.
我们报告了一例57岁男性患者,他因血清学阳性的非侵蚀性类风湿性关节炎服用柳氮磺胺吡啶20年,之后发生了一种淋巴增殖性疾病,在停用柳氮磺胺吡啶后该疾病完全缓解。这是首例关于柳氮磺胺吡啶继发淋巴增殖性疾病的报告。淋巴增殖性疾病与甲氨蝶呤和环孢素相关已广为人知,认识到这种疾病很关键,因为许多患者的症状在停药后会完全缓解,无需进一步治疗。本病例报告讨论了关于淋巴增殖性疾病的文献以及诸如药物性皮疹伴嗜酸性粒细胞增多和全身症状(DRESS)综合征等鉴别诊断。